BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37855051)

  • 1. Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study.
    Rezazadeh A; Szabo A; Khurana A; Inwards DJ; Lunning MA; Bartlett NL; Caimi PF; Rodgers TD; Barr PM; Chowdhury SM; Epperla N; Mendries H; Hill BT; Oh TS; Karmali R; Chang JE; Goyal G; Parsons BM; Isaac KM; Portell CA; Monahan K; Siker M; King DM; Fenske TS
    Haematologica; 2024 May; 109(5):1439-1444. PubMed ID: 37855051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefit of consolidative radiation therapy for primary bone diffuse large B-cell lymphoma.
    Tao R; Allen PK; Rodriguez A; Shihadeh F; Pinnix CC; Arzu I; Reed VK; Oki Y; Westin JR; Fayad LE; Medeiros LJ; Dabaja B
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):122-9. PubMed ID: 25754633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.
    Jegadeesh N; Rajpara R; Esiashvili N; Shi Z; Liu Y; Okwan-Duodu D; Flowers CR; Khan MK
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):107-12. PubMed ID: 25863758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-institutional and case-matched control study on treatment outcomes of consolidative radiotherapy after a full course of R-CHOP compared with R-CHOP alone in Stage I-II diffuse large B-cell lymphoma (KROG 17-02).
    Chung MJ; Cho WK; Oh D; Eom KY; Kim JH; Kim WC; Lee JH
    J Radiat Res; 2019 Oct; 60(5):677-684. PubMed ID: 31251343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of consolidative radiation therapy for patients with mediastinal diffuse large B-cell lymphoma in the rituximab era.
    Sert F; Kamer S; Saydam G; Anacak Y
    J Cancer Res Ther; 2018; 14(6):1397-1402. PubMed ID: 30488862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of radiotherapy for patients over age 60 with diffuse large B-cell lymphoma in the rituximab era.
    Cassidy RJ; Jegadeesh N; Switchenko J; Danish H; Esiashvili N; Flowers CR; Khan MK
    Leuk Lymphoma; 2016 Aug; 57(8):1876-82. PubMed ID: 26759182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy.
    Shi Z; Das S; Okwan-Duodu D; Esiashvili N; Flowers C; Chen Z; Wang X; Jiang K; Nastoupil LJ; Khan MK
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):569-77. PubMed ID: 23540349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of radiation therapy in primary breast diffuse large B-cell lymphoma in the Rituximab era: a SEER database analysis.
    Liu PP; Wang KF; Jin JT; Bi XW; Sun P; Wang Y; Yang H; Li ZM; Jiang WQ; Xia Y
    Cancer Med; 2018 May; 7(5):1845-1851. PubMed ID: 29624913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy.
    Phan J; Mazloom A; Medeiros LJ; Zreik TG; Wogan C; Shihadeh F; Rodriguez MA; Fayad L; Fowler N; Reed V; Horace P; Dabaja BS
    J Clin Oncol; 2010 Sep; 28(27):4170-6. PubMed ID: 20713859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based Study.
    Fluge Ø; Mannsåker B; Torp A; Mjaaland I; Helgeland L; Klos J; Mella O; Berentsen S; Meyer P
    Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):125-135.e3. PubMed ID: 29352718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era.
    Bobillo S; Joffe E; Lavery JA; Sermer D; Ghione P; Noy A; Caron PC; Hamilton A; Hamlin PA; Horwitz SM; Kumar A; Matasar MJ; Moskowitz A; Owens CN; Palomba ML; Batlevi CL; Straus D; von Keudell G; Zelenetz AD; Yahalom J; Dogan A; Seshan VE; Younes A
    Blood; 2021 Jan; 137(1):39-48. PubMed ID: 32730585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after Rituximab: A population-based analysis.
    Haque W; Dabaja B; Tann A; Khan M; Szeja S; Butler EB; Teh BS
    Radiother Oncol; 2016 Jul; 120(1):150-5. PubMed ID: 27373911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features, management, and prognosis of an international series of 161 patients with limited-stage diffuse large B-cell lymphoma of the bone (the IELSG-14 study).
    Bruno Ventre M; Ferreri AJ; Gospodarowicz M; Govi S; Messina C; Porter D; Radford J; Heo DS; Park Y; Martinelli G; Taylor E; Lucraft H; Hong A; Scarfò L; Zucca E; Christie D;
    Oncologist; 2014 Mar; 19(3):291-8. PubMed ID: 24567283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of PET-guided radiation in patients with advanced-stage diffuse large B-cell lymphoma treated with R-CHOP.
    Freeman CL; Savage KJ; Villa DR; Scott DW; Srour L; Gerrie AS; Brown MJ; Slack GW; Farinha P; Skinnider B; Morris J; Bénard F; Aquino-Parsons C; Lo A; Pickles T; Wilson DC; Tonseth P; Connors JM; Sehn LH
    Blood; 2021 Feb; 137(7):929-938. PubMed ID: 32871586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy?
    Vargo JA; Gill BS; Balasubramani GK; Beriwal S
    J Clin Oncol; 2015 Nov; 33(32):3710-7. PubMed ID: 26261253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma.
    Chan EHL; Koh LP; Lee J; De Mel S; Jeyasekharan A; Liu X; Tang T; Lim ST; Tao M; Quek R; Farid Bin Harunal Ras M; Lee YS; Diong C; Tan D; Kim SJ; Chee YL; Poon LMM
    Cancer Med; 2019 Aug; 8(10):4626-4632. PubMed ID: 31264808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Strategies and Prognostic Factors of Primary Gastric Diffuse Large B Cell Lymphoma: A Retrospective Multicenter Study of 272 Cases from the China Lymphoma Patient Registry.
    Yang H; Wu M; Shen Y; Lei T; Mi L; Leng X; Ping L; Xie Y; Song Y; Cen X; Zhu J
    Int J Med Sci; 2019; 16(7):1023-1031. PubMed ID: 31341416
    [No Abstract]   [Full Text] [Related]  

  • 18. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project.
    Dabaja BS; Vanderplas AM; Crosby-Thompson AL; Abel GA; Czuczman MS; Friedberg JW; Gordon LI; Kaminski M; Niland J; Millenson M; Nademanee AP; Zelenetz A; LaCasce AS; Rodriguez MA
    Cancer; 2015 Apr; 121(7):1032-9. PubMed ID: 25492236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of HIV infection on consolidative radiotherapy for non-Hodgkin diffuse large B-cell lymphoma.
    Medici CTM; Mauro GP; Casimiro LC; Weltman E
    Radiat Oncol; 2020 Jun; 15(1):153. PubMed ID: 32539797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.